AirPress Medicine section covers the latest developments in medical research, pharmaceutical innovation, and public health. We report on clinical trials, new treatments, disease outbreaks, and healthcare policy from around the world. Our editors translate complex scientific findings into clear, reliable information for patients, caregivers, and health-conscious readers. From breakthrough cancer therapies to everyday wellness advice, AirPress Medicine is committed to keeping you informed about the science of health and the future of medicine.
Eli Lilly’s retatrutide weight loss trial achieved up to 30.3% body weight reduction, matching bariatric surgery. Phase 3 TRIUMPH-1 data, mechanism, and access analysis.
A landmark blood protein genetics study in Cell identifies 4,000+ genomic regions controlling circulating proteins and reveals a drug repurposing opportunity for rheumatoid arthritis.
Mayo Clinic’s REDMOD AI detects pancreatic cancer on routine CT scans 475 days before diagnosis, nearly doubling radiologist sensitivity. Published in Gut.
Science explains why turning off WiFi and enabling airplane mode restores REM sleep and vivid dreaming. Medical analysis of EMF, melatonin and sleep architecture.
New study reveals gut neurons share 86% of brain’s neurotransmitter receptors. Enteric nervous system atlas changes neuroscience. Read full analysis.
AI-designed proteins that bind specific compounds. KAIST and Nobel laureate Baker create de novo biosensors for cortisol and drugs. Early diagnosis potential.
max 155 cific institutmorality of scientists funded by industry — tobacco, vific institut, EU herb bans. What should happen to a researcher who knowingly ific instituts.
H5N1 bird flu 2026 spreads across more species than ever. First H5N5 human case confirmed. No vaccine works. Scientists warn of a pandemic worse than COVID-19.
FDA approves Eli Lilly’s GLP-1 weight loss pill Foundayo. A once-daily oral drug that could transform obesity care. Read analysis.
Discover the historic curing of sickle-cell anemia in a 21-year-old US patient through breakthrough gene therapy! Read about the 2026 medical revolution.
Groundbreaking therapies for cancer, rare diseases & hypertension await FDA approval April 2026. Precision medicine advances signal new treatment era.
Explore the massive April 2026 medical breakthroughs, featuring revolutionary clinical trial successes in sepsis reversal, osteoarthritis, and breast cancer.
Stanford’s Project NExT achieves first safe, long-term brain-AI interface. Human cognition enhanced by 40% via neural implant. The digital citizen era begins.
The FDA just approved Eli Lilly’s Foundayo weight-loss pill. Discover how this restriction-free, $149 daily oral GLP-1 will change global obesity care.
Moderna & Merck’s mRNA cancer vaccine cuts melanoma death risk by 49% over 5 years. How this 2026 breakthrough could transform cancer treatment globally.
